According to Market IntelliX Research, the global market for Molecular Point of Care (POC) should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

China Molecular Point of Care (POC) market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

The United States Molecular Point of Care (POC) market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

In terms of type, Respiratory segment holds a share about % in 2023 and will reach % in 2030; while in terms of application, Clinical has a share approximately % in 2023 and will grow at a CAGR % during 2024 and 2030.

The global key manufacturers of Molecular Point of Care (POC) include Abbott Laboratories, Aidian Oy, Akonni Biosystems, binx health, inc., Biocartis NV, bioMérieux SA, Cepheid, Credo Bioscience and Curetis NV, etc. In 2023, the global top five players hold a share approximately % in terms of revenue.

This report aims to provide a comprehensive study of the global market for Molecular Point of Care (POC). Report Highlights:

(1) Global Molecular Point of Care (POC) market size (value),history data from 2019-2024 and forecast data from 2024 to 2030.

(2) Global Molecular Point of Care (POC) market competitive situation, revenue and market share, from 2018 to 2022.

(3) China Molecular Point of Care (POC) market competitive situation, revenue and market share, from 2018 to 2022.

(4) Global Molecular Point of Care (POC) segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.

(5) Global Molecular Point of Care (POC) segment by type and by application and regional segment by type and by application.

(6) Molecular Point of Care (POC) industry supply chain, upstream, midstream and downstream analysis.

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Market segment by type, covers

Respiratory

Other

Market segment by application, can be divided into

Clinical

Research

Market segment by players, this report covers

Abbott Laboratories

Aidian Oy

Akonni Biosystems

binx health, inc.

Biocartis NV

bioMérieux SA

Cepheid

Credo Bioscience

Curetis NV

DiaSorin S.p.A

GenMark Diagnostics

Greiner Bio-One GmbH

Meridian Bioscience, Inc.

Mesa Biotech, Inc.

QIAGEN NV

QuantuMDx Group

Quidel Corporation

Roche

Sekisui Diagnostics LLC

T2 Biosystems

1 Market Overview

1.1 Product Overview and Scope of Molecular Point of Care (POC)

1.2 Global Molecular Point of Care (POC) Market Size and Forecast

1.3 China Molecular Point of Care (POC) Market Size and Forecast

1.4 China Market Percentage in Global

1.4.1 By Revenue, China Molecular Point of Care (POC) Share in Global Market, 2019-2030

1.4.2 Molecular Point of Care (POC) Market Size: China VS Global, 2019-2030

1.5 Molecular Point of Care (POC) Market Dynamics

1.5.1 Molecular Point of Care (POC) Market Drivers

1.5.2 Molecular Point of Care (POC) Market Restraints

1.5.3 Molecular Point of Care (POC) Industry Trends

1.5.4 Molecular Point of Care (POC) Industry Policy

2 Global Competitive Situation by Company

2.1 Global Molecular Point of Care (POC) Revenue by Company (2019-2024)

2.2 Global Molecular Point of Care (POC) Participants, Market Position (Tier 1, Tier 2 and Tier 3)

2.3 Global Molecular Point of Care (POC) Concentration Ratio

2.4 Global Molecular Point of Care (POC) Mergers & Acquisitions, Expansion Plans

2.5 Global Molecular Point of Care (POC) Manufacturers Product Type

3 China Competitive Situation by Company

3.1 China Molecular Point of Care (POC) Revenue by Company (2019-2024)

3.2 China Molecular Point of Care (POC) Molecular Point of Care (POC) Participants, Market Position (Tier 1, Tier 2 and Tier 3)

3.3 China Molecular Point of Care (POC), Revenue Percentage of Local Players VS Foreign Manufacturers (2019-2024)

4 Industry Chain Analysis

4.1 Molecular Point of Care (POC) Industry Chain

4.2 Molecular Point of Care (POC) Upstream Analysis

4.3 Molecular Point of Care (POC) Midstream Analysis

4.4 Molecular Point of Care (POC) Downstream Analysis

5 Sights by Type

5.1 Molecular Point of Care (POC) Classification

5.1.1 Respiratory

5.1.2 Other

5.2 By Type, Global Molecular Point of Care (POC) Market Size & CAGR, 2019 VS 2024 VS 2030

5.3 By Type, Global Molecular Point of Care (POC) Revenue, 2019-2030

6 Sights by Application

6.1 Molecular Point of Care (POC) Segment by Application

6.1.1 Clinical

6.1.2 Research

6.2 By Application, Global Molecular Point of Care (POC) Market Size & CAGR, 2019 VS 2024 VS 2030

6.3 By Application, Global Molecular Point of Care (POC) Revenue, 2019-2030

7 Sales Sights by Region

7.1 By Region, Global Molecular Point of Care (POC) Market Size, 2019 VS 2024 VS 2030

7.2 By Region, Global Molecular Point of Care (POC) Market Size, 2019-2030

7.3 North America

7.3.1 North America Molecular Point of Care (POC) Market Size & Forecasts, 2019-2030

7.3.2 By Country, North America Molecular Point of Care (POC) Market Size Market Share

7.4 Europe

7.4.1 Europe Molecular Point of Care (POC) Market Size & Forecasts, 2019-2030

7.4.2 By Country, Europe Molecular Point of Care (POC) Market Size Market Share

7.5 Asia Pacific

7.5.1 Asia Pacific Molecular Point of Care (POC) Market Size & Forecasts, 2019-2030

7.5.2 By Country/Region, Asia Pacific Molecular Point of Care (POC) Market Size Market Share

7.6 South America

7.6.1 South America Molecular Point of Care (POC) Market Size & Forecasts, 2019-2030

7.6.2 By Country, South America Molecular Point of Care (POC) Market Size Market Share

7.7 Middle East & Africa

8 Sights by Country Level

8.1 By Country, Global Molecular Point of Care (POC) Market Size & CAGR，2019 VS 2024 VS 2030

8.2 By Country, Global Molecular Point of Care (POC) Market Size, 2019-2030

8.3 U.S.

8.3.1 U.S. Molecular Point of Care (POC) Market Size, 2019-2030

8.3.2 By Company, U.S. Molecular Point of Care (POC) Revenue Market Share, 2019-2024

8.3.3 By Type, U.S. Molecular Point of Care (POC) Revenue Market Share, 2023 VS 2030

8.3.4 By Application, U.S. Molecular Point of Care (POC) Revenue Market Share, 2023 VS 2030

8.4 Europe

8.4.1 Europe Molecular Point of Care (POC) Market Size, 2019-2030

8.4.2 By Company, Europe Molecular Point of Care (POC) Revenue Market Share, 2019-2024

8.4.3 By Type, Europe Molecular Point of Care (POC) Revenue Market Share, 2023 VS 2030

8.4.4 By Application, Europe Molecular Point of Care (POC) Revenue Market Share, 2023 VS 2030

8.5 China

8.5.1 China Molecular Point of Care (POC) Market Size, 2019-2030

8.5.2 By Company, China Molecular Point of Care (POC) Revenue Market Share, 2019-2024

8.5.3 By Type, China Molecular Point of Care (POC) Revenue Market Share, 2023 VS 2030

8.5.4 By Application, China Molecular Point of Care (POC) Revenue Market Share, 2023 VS 2030

8.6 Japan

8.6.1 Japan Molecular Point of Care (POC) Market Size, 2019-2030

8.6.2 By Company, Japan Molecular Point of Care (POC) Revenue Market Share, 2019-2024

8.6.3 By Type, Japan Molecular Point of Care (POC) Revenue Market Share, 2023 VS 2030

8.6.4 By Application, Japan Molecular Point of Care (POC) Revenue Market Share, 2023 VS 2030

8.7 South Korea

8.7.1 South Korea Molecular Point of Care (POC) Market Size, 2019-2030

8.7.2 By Company, South Korea Molecular Point of Care (POC) Revenue Market Share, 2019-2024

8.7.3 By Type, South Korea Molecular Point of Care (POC) Revenue Market Share, 2023 VS 2030

8.7.4 By Application, South Korea Molecular Point of Care (POC) Revenue Market Share, 2023 VS 2030

8.8 Southeast Asia

8.8.1 Southeast Asia Molecular Point of Care (POC) Market Size, 2019-2030

8.8.2 By Company, Southeast Asia Molecular Point of Care (POC) Revenue Market Share, 2019-2024

8.8.3 By Type, Southeast Asia Molecular Point of Care (POC) Revenue Market Share, 2023 VS 2030

8.8.4 By Application, Southeast Asia Molecular Point of Care (POC) Revenue Market Share, 2023 VS 2030

8.9 India

8.9.1 India Molecular Point of Care (POC) Market Size, 2019-2030

8.9.2 By Company, India Molecular Point of Care (POC) Revenue Market Share, 2019-2024

8.9.3 By Type, India Molecular Point of Care (POC) Revenue Market Share, 2023 VS 2030

8.9.4 By Application, India Molecular Point of Care (POC) Revenue Market Share, 2023 VS 2030

8.10 Middle East & Asia

8.10.1 Middle East & Asia Molecular Point of Care (POC) Market Size, 2019-2030

8.10.2 By Company, Middle East & Asia Molecular Point of Care (POC) Revenue Market Share, 2019-2024

8.10.3 By Type, Middle East & Asia Molecular Point of Care (POC) Revenue Market Share, 2023 VS 2030

8.10.4 By Application, Middle East & Asia Molecular Point of Care (POC) Revenue Market Share, 2023 VS 2030

9 Global Manufacturers Profile

9.1 Abbott Laboratories

9.1.1 Abbott Laboratories Company Information, Head Office, Market Area and Industry Position

9.1.2 Abbott Laboratories Company Profile and Main Business

9.1.3 Abbott Laboratories Molecular Point of Care (POC) Models, Specifications and Application

9.1.4 Abbott Laboratories Molecular Point of Care (POC) Revenue and Gross Margin, 2019-2024

9.1.5 Abbott Laboratories Recent Developments

9.2 Aidian Oy

9.2.1 Aidian Oy Company Information, Head Office, Market Area and Industry Position

9.2.2 Aidian Oy Company Profile and Main Business

9.2.3 Aidian Oy Molecular Point of Care (POC) Models, Specifications and Application

9.2.4 Aidian Oy Molecular Point of Care (POC) Revenue and Gross Margin, 2019-2024

9.2.5 Aidian Oy Recent Developments

9.3 Akonni Biosystems

9.3.1 Akonni Biosystems Company Information, Head Office, Market Area and Industry Position

9.3.2 Akonni Biosystems Company Profile and Main Business

9.3.3 Akonni Biosystems Molecular Point of Care (POC) Models, Specifications and Application

9.3.4 Akonni Biosystems Molecular Point of Care (POC) Revenue and Gross Margin, 2019-2024

9.3.5 Akonni Biosystems Recent Developments

9.4 binx health, inc.

9.4.1 binx health, inc. Company Information, Head Office, Market Area and Industry Position

9.4.2 binx health, inc. Company Profile and Main Business

9.4.3 binx health, inc. Molecular Point of Care (POC) Models, Specifications and Application

9.4.4 binx health, inc. Molecular Point of Care (POC) Revenue and Gross Margin, 2019-2024

9.4.5 binx health, inc. Recent Developments

9.5 Biocartis NV

9.5.1 Biocartis NV Company Information, Head Office, Market Area and Industry Position

9.5.2 Biocartis NV Company Profile and Main Business

9.5.3 Biocartis NV Molecular Point of Care (POC) Models, Specifications and Application

9.5.4 Biocartis NV Molecular Point of Care (POC) Revenue and Gross Margin, 2019-2024

9.5.5 Biocartis NV Recent Developments

9.6 bioMérieux SA

9.6.1 bioMérieux SA Company Information, Head Office, Market Area and Industry Position

9.6.2 bioMérieux SA Company Profile and Main Business

9.6.3 bioMérieux SA Molecular Point of Care (POC) Models, Specifications and Application

9.6.4 bioMérieux SA Molecular Point of Care (POC) Revenue and Gross Margin, 2019-2024

9.6.5 bioMérieux SA Recent Developments

9.7 Cepheid

9.7.1 Cepheid Company Information, Head Office, Market Area and Industry Position

9.7.2 Cepheid Company Profile and Main Business

9.7.3 Cepheid Molecular Point of Care (POC) Models, Specifications and Application

9.7.4 Cepheid Molecular Point of Care (POC) Revenue and Gross Margin, 2019-2024

9.7.5 Cepheid Recent Developments

9.8 Credo Bioscience

9.8.1 Credo Bioscience Company Information, Head Office, Market Area and Industry Position

9.8.2 Credo Bioscience Company Profile and Main Business

9.8.3 Credo Bioscience Molecular Point of Care (POC) Models, Specifications and Application

9.8.4 Credo Bioscience Molecular Point of Care (POC) Revenue and Gross Margin, 2019-2024

9.8.5 Credo Bioscience Recent Developments

9.9 Curetis NV

9.9.1 Curetis NV Company Information, Head Office, Market Area and Industry Position

9.9.2 Curetis NV Company Profile and Main Business

9.9.3 Curetis NV Molecular Point of Care (POC) Models, Specifications and Application

9.9.4 Curetis NV Molecular Point of Care (POC) Revenue and Gross Margin, 2019-2024

9.9.5 Curetis NV Recent Developments

9.10 DiaSorin S.p.A

9.10.1 DiaSorin S.p.A Company Information, Head Office, Market Area and Industry Position

9.10.2 DiaSorin S.p.A Company Profile and Main Business

9.10.3 DiaSorin S.p.A Molecular Point of Care (POC) Models, Specifications and Application

9.10.4 DiaSorin S.p.A Molecular Point of Care (POC) Revenue and Gross Margin, 2019-2024

9.10.5 DiaSorin S.p.A Recent Developments

9.11 GenMark Diagnostics

9.11.1 GenMark Diagnostics Company Information, Head Office, Market Area and Industry Position

9.11.2 GenMark Diagnostics Company Profile and Main Business

9.11.3 GenMark Diagnostics Molecular Point of Care (POC) Models, Specifications and Application

9.11.4 GenMark Diagnostics Molecular Point of Care (POC) Revenue and Gross Margin, 2019-2024

9.11.5 GenMark Diagnostics Recent Developments

9.12 Greiner Bio-One GmbH

9.12.1 Greiner Bio-One GmbH Company Information, Head Office, Market Area and Industry Position

9.12.2 Greiner Bio-One GmbH Company Profile and Main Business

9.12.3 Greiner Bio-One GmbH Molecular Point of Care (POC) Models, Specifications and Application

9.12.4 Greiner Bio-One GmbH Molecular Point of Care (POC) Revenue and Gross Margin, 2019-2024

9.12.5 Greiner Bio-One GmbH Recent Developments

9.13 Meridian Bioscience, Inc.

9.13.1 Meridian Bioscience, Inc. Company Information, Head Office, Market Area and Industry Position

9.13.2 Meridian Bioscience, Inc. Company Profile and Main Business

9.13.3 Meridian Bioscience, Inc. Molecular Point of Care (POC) Models, Specifications and Application

9.13.4 Meridian Bioscience, Inc. Molecular Point of Care (POC) Revenue and Gross Margin, 2019-2024

9.13.5 Meridian Bioscience, Inc. Recent Developments

9.14 Mesa Biotech, Inc.

9.14.1 Mesa Biotech, Inc. Company Information, Head Office, Market Area and Industry Position

9.14.2 Mesa Biotech, Inc. Company Profile and Main Business

9.14.3 Mesa Biotech, Inc. Molecular Point of Care (POC) Models, Specifications and Application

9.14.4 Mesa Biotech, Inc. Molecular Point of Care (POC) Revenue and Gross Margin, 2019-2024

9.14.5 Mesa Biotech, Inc. Recent Developments

9.15 QIAGEN NV

9.15.1 QIAGEN NV Company Information, Head Office, Market Area and Industry Position

9.15.2 QIAGEN NV Company Profile and Main Business

9.15.3 QIAGEN NV Molecular Point of Care (POC) Models, Specifications and Application

9.15.4 QIAGEN NV Molecular Point of Care (POC) Revenue and Gross Margin, 2019-2024

9.15.5 QIAGEN NV Recent Developments

9.16 QuantuMDx Group

9.16.1 QuantuMDx Group Company Information, Head Office, Market Area and Industry Position

9.16.2 QuantuMDx Group Company Profile and Main Business

9.16.3 QuantuMDx Group Molecular Point of Care (POC) Models, Specifications and Application

9.16.4 QuantuMDx Group Molecular Point of Care (POC) Revenue and Gross Margin, 2019-2024

9.16.5 QuantuMDx Group Recent Developments

9.17 Quidel Corporation

9.17.1 Quidel Corporation Company Information, Head Office, Market Area and Industry Position

9.17.2 Quidel Corporation Company Profile and Main Business

9.17.3 Quidel Corporation Molecular Point of Care (POC) Models, Specifications and Application

9.17.4 Quidel Corporation Molecular Point of Care (POC) Revenue and Gross Margin, 2019-2024

9.17.5 Quidel Corporation Recent Developments

9.18 Roche

9.18.1 Roche Company Information, Head Office, Market Area and Industry Position

9.18.2 Roche Company Profile and Main Business

9.18.3 Roche Molecular Point of Care (POC) Models, Specifications and Application

9.18.4 Roche Molecular Point of Care (POC) Revenue and Gross Margin, 2019-2024

9.18.5 Roche Recent Developments

9.19 Sekisui Diagnostics LLC

9.19.1 Sekisui Diagnostics LLC Company Information, Head Office, Market Area and Industry Position

9.19.2 Sekisui Diagnostics LLC Company Profile and Main Business

9.19.3 Sekisui Diagnostics LLC Molecular Point of Care (POC) Models, Specifications and Application

9.19.4 Sekisui Diagnostics LLC Molecular Point of Care (POC) Revenue and Gross Margin, 2019-2024

9.19.5 Sekisui Diagnostics LLC Recent Developments

9.20 T2 Biosystems

9.20.1 T2 Biosystems Company Information, Head Office, Market Area and Industry Position

9.20.2 T2 Biosystems Company Profile and Main Business

9.20.3 T2 Biosystems Molecular Point of Care (POC) Models, Specifications and Application

9.20.4 T2 Biosystems Molecular Point of Care (POC) Revenue and Gross Margin, 2019-2024

9.20.5 T2 Biosystems Recent Developments

10 Conclusion

11 Appendix

11.1 Research Methodology

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Market Estimation Model

11.4 Disclaimer

Table 1. Molecular Point of Care (POC) Market Size & CAGR: China VS Global, (US$ Million), 2019-2030

Table 2. Molecular Point of Care (POC) Market Restraints

Table 3. Molecular Point of Care (POC) Market Trends

Table 4. Molecular Point of Care (POC) Industry Policy

Table 5. Global Molecular Point of Care (POC) Revenue by Company (2019-2024) & (US$ million)

Table 6. Global Molecular Point of Care (POC) Revenue Market Share by Company (2019-2024)

Table 7. Global Molecular Point of Care (POC) Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 8. Global Molecular Point of Care (POC) Mergers & Acquisitions, Expansion Plans

Table 9. Global Molecular Point of Care (POC) Manufacturers Product Type

Table 10. China Molecular Point of Care (POC) Revenue by Company (2019-2024) & (US$ million)

Table 11. China Molecular Point of Care (POC) Revenue Market Share by Company (2019-2024)

Table 12. Global Key Players of Molecular Point of Care (POC) Upstream (Raw Materials)

Table 13. Global Molecular Point of Care (POC) Typical Customers

Table 14. Molecular Point of Care (POC) Typical Distributors

Table 15. By Type, Global Molecular Point of Care (POC) Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 16. By Application, Global Molecular Point of Care (POC) Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 17. By Region, Global Molecular Point of Care (POC) Market Size, 2019 VS 2024 VS 2030, US$ Million

Table 18. By Region, Global Molecular Point of Care (POC) Revenue, 2019-2030, US$ Million

Table 19. By Country, Global Molecular Point of Care (POC) Revenue & CAGR，2019 VS 2024 VS 2030, US$ Million

Table 20. By Country, Global Molecular Point of Care (POC) Revenue, 2019-2030, US$ Million

Table 21. By Country, Global Molecular Point of Care (POC) Revenue Market Share, 2019-2030

Table 22. Abbott Laboratories Company Information, Head Office, Market Area and Industry Position

Table 23. Abbott Laboratories Company Profile and Main Business

Table 24. Abbott Laboratories Molecular Point of Care (POC) Models, Specifications and Application

Table 25. Abbott Laboratories Molecular Point of Care (POC) Revenue and Gross Margin, 2019-2024

Table 26. Abbott Laboratories Recent Developments

Table 27. Aidian Oy Company Information, Head Office, Market Area and Industry Position

Table 28. Aidian Oy Company Profile and Main Business

Table 29. Aidian Oy Molecular Point of Care (POC) Models, Specifications and Application

Table 30. Aidian Oy Molecular Point of Care (POC) Revenue and Gross Margin, 2019-2024

Table 31. Aidian Oy Recent Developments

Table 32. Akonni Biosystems Company Information, Head Office, Market Area and Industry Position

Table 33. Akonni Biosystems Company Profile and Main Business

Table 34. Akonni Biosystems Molecular Point of Care (POC) Models, Specifications and Application

Table 35. Akonni Biosystems Molecular Point of Care (POC) Revenue and Gross Margin, 2019-2024

Table 36. Akonni Biosystems Recent Developments

Table 37. binx health, inc. Company Information, Head Office, Market Area and Industry Position

Table 38. binx health, inc. Company Profile and Main Business

Table 39. binx health, inc. Molecular Point of Care (POC) Models, Specifications and Application

Table 40. binx health, inc. Molecular Point of Care (POC) Revenue and Gross Margin, 2019-2024

Table 41. binx health, inc. Recent Developments

Table 42. Biocartis NV Company Information, Head Office, Market Area and Industry Position

Table 43. Biocartis NV Company Profile and Main Business

Table 44. Biocartis NV Molecular Point of Care (POC) Models, Specifications and Application

Table 45. Biocartis NV Molecular Point of Care (POC) Revenue and Gross Margin, 2019-2024

Table 46. Biocartis NV Recent Developments

Table 47. bioMérieux SA Company Information, Head Office, Market Area and Industry Position

Table 48. bioMérieux SA Company Profile and Main Business

Table 49. bioMérieux SA Molecular Point of Care (POC) Models, Specifications and Application

Table 50. bioMérieux SA Molecular Point of Care (POC) Revenue and Gross Margin, 2019-2024

Table 51. bioMérieux SA Recent Developments

Table 52. Cepheid Company Information, Head Office, Market Area and Industry Position

Table 53. Cepheid Company Profile and Main Business

Table 54. Cepheid Molecular Point of Care (POC) Models, Specifications and Application

Table 55. Cepheid Molecular Point of Care (POC) Revenue and Gross Margin, 2019-2024

Table 56. Cepheid Recent Developments

Table 57. Credo Bioscience Company Information, Head Office, Market Area and Industry Position

Table 58. Credo Bioscience Company Profile and Main Business

Table 59. Credo Bioscience Molecular Point of Care (POC) Models, Specifications and Application

Table 60. Credo Bioscience Molecular Point of Care (POC) Revenue and Gross Margin, 2019-2024

Table 61. Credo Bioscience Recent Developments

Table 62. Curetis NV Company Information, Head Office, Market Area and Industry Position

Table 63. Curetis NV Company Profile and Main Business

Table 64. Curetis NV Molecular Point of Care (POC) Models, Specifications and Application

Table 65. Curetis NV Molecular Point of Care (POC) Revenue and Gross Margin, 2019-2024

Table 66. Curetis NV Recent Developments

Table 67. DiaSorin S.p.A Company Information, Head Office, Market Area and Industry Position

Table 68. DiaSorin S.p.A Company Profile and Main Business

Table 69. DiaSorin S.p.A Molecular Point of Care (POC) Models, Specifications and Application

Table 70. DiaSorin S.p.A Molecular Point of Care (POC) Revenue and Gross Margin, 2019-2024

Table 71. DiaSorin S.p.A Recent Developments

Table 72. GenMark Diagnostics Company Information, Head Office, Market Area and Industry Position

Table 73. GenMark Diagnostics Company Profile and Main Business

Table 74. GenMark Diagnostics Molecular Point of Care (POC) Models, Specifications and Application

Table 75. GenMark Diagnostics Molecular Point of Care (POC) Revenue and Gross Margin, 2019-2024

Table 76. GenMark Diagnostics Recent Developments

Table 77. Greiner Bio-One GmbH Company Information, Head Office, Market Area and Industry Position

Table 78. Greiner Bio-One GmbH Company Profile and Main Business

Table 79. Greiner Bio-One GmbH Molecular Point of Care (POC) Models, Specifications and Application

Table 80. Greiner Bio-One GmbH Molecular Point of Care (POC) Revenue and Gross Margin, 2019-2024

Table 81. Greiner Bio-One GmbH Recent Developments

Table 82. Meridian Bioscience, Inc. Company Information, Head Office, Market Area and Industry Position

Table 83. Meridian Bioscience, Inc. Company Profile and Main Business

Table 84. Meridian Bioscience, Inc. Molecular Point of Care (POC) Models, Specifications and Application

Table 85. Meridian Bioscience, Inc. Molecular Point of Care (POC) Revenue and Gross Margin, 2019-2024

Table 86. Meridian Bioscience, Inc. Recent Developments

Table 87. Mesa Biotech, Inc. Company Information, Head Office, Market Area and Industry Position

Table 88. Mesa Biotech, Inc. Company Profile and Main Business

Table 89. Mesa Biotech, Inc. Molecular Point of Care (POC) Models, Specifications and Application

Table 90. Mesa Biotech, Inc. Molecular Point of Care (POC) Revenue and Gross Margin, 2019-2024

Table 91. Mesa Biotech, Inc. Recent Developments

Table 92. QIAGEN NV Company Information, Head Office, Market Area and Industry Position

Table 93. QIAGEN NV Company Profile and Main Business

Table 94. QIAGEN NV Molecular Point of Care (POC) Models, Specifications and Application

Table 95. QIAGEN NV Molecular Point of Care (POC) Revenue and Gross Margin, 2019-2024

Table 96. QIAGEN NV Recent Developments

Table 97. QuantuMDx Group Company Information, Head Office, Market Area and Industry Position

Table 98. QuantuMDx Group Company Profile and Main Business

Table 99. QuantuMDx Group Molecular Point of Care (POC) Models, Specifications and Application

Table 100. QuantuMDx Group Molecular Point of Care (POC) Revenue and Gross Margin, 2019-2024

Table 101. QuantuMDx Group Recent Developments

Table 102. Quidel Corporation Company Information, Head Office, Market Area and Industry Position

Table 103. Quidel Corporation Company Profile and Main Business

Table 104. Quidel Corporation Molecular Point of Care (POC) Models, Specifications and Application

Table 105. Quidel Corporation Molecular Point of Care (POC) Revenue and Gross Margin, 2019-2024

Table 106. Quidel Corporation Recent Developments

Table 107. Roche Company Information, Head Office, Market Area and Industry Position

Table 108. Roche Company Profile and Main Business

Table 109. Roche Molecular Point of Care (POC) Models, Specifications and Application

Table 110. Roche Molecular Point of Care (POC) Revenue and Gross Margin, 2019-2024

Table 111. Roche Recent Developments

Table 112. Sekisui Diagnostics LLC Company Information, Head Office, Market Area and Industry Position

Table 113. Sekisui Diagnostics LLC Company Profile and Main Business

Table 114. Sekisui Diagnostics LLC Molecular Point of Care (POC) Models, Specifications and Application

Table 115. Sekisui Diagnostics LLC Molecular Point of Care (POC) Revenue and Gross Margin, 2019-2024

Table 116. Sekisui Diagnostics LLC Recent Developments

Table 117. T2 Biosystems Company Information, Head Office, Market Area and Industry Position

Table 118. T2 Biosystems Company Profile and Main Business

Table 119. T2 Biosystems Molecular Point of Care (POC) Models, Specifications and Application

Table 120. T2 Biosystems Molecular Point of Care (POC) Revenue and Gross Margin, 2019-2024

Table 121. T2 Biosystems Recent Developments

List of Figure

Figure 1. Molecular Point of Care (POC) Picture

Figure 2. Global Molecular Point of Care (POC) Industry Market Size and Forecast (US$ million) & (2019-2030)

Figure 3. China Molecular Point of Care (POC) Revenue and Forecast (US$ million) & (2019-2030)

Figure 4. 2019-2030 China Molecular Point of Care (POC) Market Share of Global

Figure 5. Global Molecular Point of Care (POC) Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 6. Global Molecular Point of Care (POC) Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2019-2024

Figure 7. China Molecular Point of Care (POC) Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 8. China Molecular Point of Care (POC) Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2019-2024

Figure 9. Molecular Point of Care (POC) Industry Chain

Figure 10. Respiratory

Figure 11. Other

Figure 12. By Type, Global Molecular Point of Care (POC) Revenue, 2019-2030, US$ Million

Figure 13. By Type, Global Molecular Point of Care (POC) Revenue Market Share, 2019-2030

Figure 14. Clinical

Figure 15. Research

Figure 16. By Application, Global Molecular Point of Care (POC) Revenue, 2019-2030, US$ Million

Figure 17. By Application, Global Molecular Point of Care (POC) Revenue Market Share, 2019-2030

Figure 18. By Region, Global Molecular Point of Care (POC) Revenue Market Share, 2019-2030

Figure 19. North America Molecular Point of Care (POC) Revenue & Forecasts, 2019-2030, US$ Million

Figure 20. By Country, North America Molecular Point of Care (POC) Revenue Market Share, 2019-2024

Figure 21. Europe Molecular Point of Care (POC) Revenue & Forecasts, 2019-2030, US$ Million

Figure 22. By Country, Europe Molecular Point of Care (POC) Revenue Market Share, 2019-2024

Figure 23. Asia Pacific Molecular Point of Care (POC) Revenue & Forecasts, 2019-2030, US$ Million

Figure 24. By Country/Region, Asia Pacific Molecular Point of Care (POC) Revenue Market Share, 2019-2024

Figure 25. South America Molecular Point of Care (POC) Revenue & Forecasts, 2019-2030, US$ Million

Figure 26. By Country, South America Molecular Point of Care (POC) Revenue Market Share, 2019-2024

Figure 27. Middle East & Africa Molecular Point of Care (POC) Revenue & Forecasts, 2019-2030, US$ Million

Figure 28. U.S. Molecular Point of Care (POC) Revenue, 2019-2030, (US$ Million)

Figure 29. By Company, U.S. Molecular Point of Care (POC) Market Share, 2019-2024

Figure 30. By Type, U.S. Molecular Point of Care (POC) Revenue Market Share, 2022 VS 2029

Figure 31. By Application, U.S. Molecular Point of Care (POC) Revenue Market Share, 2022 VS 2029

Figure 32. Europe Molecular Point of Care (POC) Revenue, 2019-2030, (US$ Million)

Figure 33. By Company, Europe Molecular Point of Care (POC) Market Share, 2019-2024

Figure 34. By Type, Europe Molecular Point of Care (POC) Revenue Market Share, 2022 VS 2029

Figure 35. By Application, Europe Molecular Point of Care (POC) Revenue Market Share, 2022 VS 2029

Figure 36. China Molecular Point of Care (POC) Revenue, 2019-2030, (US$ Million)

Figure 37. By Company, China Molecular Point of Care (POC) Market Share, 2019-2024

Figure 38. By Type, China Molecular Point of Care (POC) Revenue Market Share, 2022 VS 2029

Figure 39. By Application, China Molecular Point of Care (POC) Revenue Market Share, 2022 VS 2029

Figure 40. Japan Molecular Point of Care (POC) Revenue, 2019-2030, (US$ Million)

Figure 41. By Company, Japan Molecular Point of Care (POC) Market Share, 2019-2024

Figure 42. By Type, Japan Molecular Point of Care (POC) Revenue Market Share, 2022 VS 2029

Figure 43. By Application, Japan Molecular Point of Care (POC) Revenue Market Share, 2022 VS 2029

Figure 44. South Korea Molecular Point of Care (POC) Revenue, 2019-2030, (US$ Million)

Figure 45. By Company, South Korea Molecular Point of Care (POC) Market Share, 2019-2024

Figure 46. By Type, South Korea Molecular Point of Care (POC) Revenue Market Share, 2022 VS 2029

Figure 47. By Application, South Korea Molecular Point of Care (POC) Revenue Market Share, 2022 VS 2029

Figure 48. Southeast Asia Molecular Point of Care (POC) Revenue, 2019-2030, (US$ Million)

Figure 49. By Company, Southeast Asia Molecular Point of Care (POC) Market Share, 2019-2024

Figure 50. By Type, Southeast Asia Molecular Point of Care (POC) Revenue Market Share, 2022 VS 2029

Figure 51. By Application, Southeast Asia Molecular Point of Care (POC) Revenue Market Share, 2022 VS 2029

Figure 52. India Molecular Point of Care (POC) Revenue, 2019-2030, (US$ Million)

Figure 53. By Company, India Molecular Point of Care (POC) Market Share, 2019-2024

Figure 54. By Type, India Molecular Point of Care (POC) Revenue Market Share, 2022 VS 2029

Figure 55. By Application, India Molecular Point of Care (POC) Revenue Market Share, 2022 VS 2029

Figure 56. Middle East & Asia Molecular Point of Care (POC) Revenue, 2019-2030, (US$ Million)

Figure 57. By Company, Middle East & Asia Molecular Point of Care (POC) Market Share, 2019-2024

Figure 58. By Type, Middle East & Asia Molecular Point of Care (POC) Revenue Market Share, 2022 VS 2029

Figure 59. By Application, Middle East & Asia Molecular Point of Care (POC) Revenue Market Share, 2022 VS 2029

Figure 60. Research Methodology

Figure 61. Breakdown of Primary Interviews

Figure 62. Bottom-up Approaches

Figure 63. Top-down Approaches

Methodology/Research Approach

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Research Programs/Design

Historical Data (2015-2019)	Industry Trends Competitive Landscape By Company Expansion Mergers and Acquisitions Market Segment by Type by Application By Regions/ Geography	Value Status and Outlook Value for Major Players Market Share Growth Rate Present Situation Analysis Value Market Share Growth Rate Present Situation Analysis
Influencing Factors	Market Environment Government Policy Technological Changes Market Risks	Market Drivers Growing Demand of Downstream Reduction in Cost
Market Forecast (2021-2026)	Overall Size by Type by Application By Regions/Geography	Key Data (Value) Market Share Growth Rate CAGR (2021-2026)

Market Size Estimation

Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).

The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Data Source

Secondary Sources

Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Market Size	Segmental value Geographic Penetration Product Adoption Rate for Different market	Journals, Websites, and Press Releases Annual Reports and SEC Filings Company Websites and Press Releases Public and Paid Databases Market Intellix Data Repository
Market Position of Top Company	Product Financials Geographic value Mix Total Company value Business/Segmental value Mix
Qualitative Analysis	Influence Factors Market Potential Market Risks and Opportunities Industry Trends Geographical Features Government Policies	Company Websites and Press Releases Public and Paid Databases Annual Reports Industry Associations Market Intellix Data Repository

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.

Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Key Executives Interviewed

Key Data Information from Primary Sources

Primary Sources	Parameters	Key Data
Market Segments(by Application, by Type)	Value by Type Status and Forecast Value by Application Value by Regions, Status and Forecast (2021-2026)	Value Market Share by Type Value Growth Rate by Type Value by Application Percentage and Growth Rate by Application Value Growth Rate and Market Share by Regions Market Size Status and Forecast (2021-2026)
Total Market	Overall Size, Status and Forecast	Market Size Status and Forecast (2021-2026)